Samuel, R., Attard, A., & Kyriakopoulos, M. (2013). Mental state deterioration after switching from brand-name to generic olanzapine in an adolescent with bipolar affective disorder, autism and intellectual disability: A case study. BioMed Central.
Styl ChicagoSamuel, Rani, Azizah Attard, a Marinos Kyriakopoulos. Mental State Deterioration After Switching From Brand-name to Generic Olanzapine in an Adolescent With Bipolar Affective Disorder, Autism and Intellectual Disability: A Case Study. BioMed Central, 2013.
Citace podle MLASamuel, Rani, Azizah Attard, a Marinos Kyriakopoulos. Mental State Deterioration After Switching From Brand-name to Generic Olanzapine in an Adolescent With Bipolar Affective Disorder, Autism and Intellectual Disability: A Case Study. BioMed Central, 2013.